Related Experiment Video
Updated: Oct 24, 2025

A Suppressor Screen for the Characterization of Genetic Links Regulating Chronological Lifespan in Saccharomyces cerevisiae
Published on: September 17, 2020
p21-Activated kinase 1 (PAK1) in aging and longevity: An overview
Mohankumar Amirthalingam1, Sundararaj Palanisamy2, Shinkichi Tawata1
1PAK Research Center, University of the Ryukyus, Senbaru 1, Nishihara-cho, Okinawa 903-0213, Japan.
Abstract:
The p21-activated kinases (PAKs) belong to serine/threonine kinases family, regulated by ∼21 kDa small signaling G proteins RAC1 and CDC42. The mammalian PAK family comprises six members (PAK1-6) that are classified into two groups (I and II) based on their domain architecture and regulatory mechanisms. PAKs are implicated in a wide range of cellular functions. PAK1 has recently attracted increasing attention owing to its involvement in oncogenesis, tumor progression, and metastasis as well as several life-limiting diseases and pathological conditions. In Caenorhabditis elegans, PAK1 functions limit the lifespan under basal conditions by inhibiting forkhead transcription factor DAF-16. Interestingly, PAK depletion extended longevity and attenuated the onset of age-related phenotypes in a premature-aging mouse model and delayed senescence in mammalian fibroblasts. These observations implicate PAKs as not only oncogenic but also aging kinases. Therefore, PAK-targeting genetic and/or pharmacological interventions, particularly PAK1-targeting, could be a viable strategy for developing cancer therapies with relatively no side effects and promoting healthy longevity. This review describes PAK family proteins, their biological functions, and their role in regulating aging and longevity using C. elegans. Moreover, we discuss the effect of small-molecule PAK1 inhibitors on the lifespan and healthspan of C. elegans.
Insights
p21-activated kinases (PAKs) regulate lifespan and aging. Inhibiting PAK1 may offer a dual strategy for cancer therapy and promoting healthy longevity.
Area of Science:
- Molecular Biology
- Genetics
- Gerontology
Background:
- p21-activated kinases (PAKs) are serine/threonine kinases involved in diverse cellular functions.
- The PAK family, including PAK1, is implicated in oncogenesis, tumor progression, and age-related diseases.
- PAK1 activity has been shown to limit lifespan in Caenorhabditis elegans by inhibiting DAF-16.
Purpose of the Study:
- To review the biological functions of PAK family proteins.
- To explore the role of PAKs in regulating aging and longevity.
- To discuss the potential of PAK1 inhibitors for therapeutic interventions.
Main Methods:
- Literature review of PAK family proteins and their functions.
- Analysis of studies on PAKs in aging models, including C. elegans and mouse models.
- Discussion of small-molecule PAK1 inhibitors and their effects on lifespan and healthspan.
Main Results:
- PAK1 activity shortens lifespan in C. elegans.
- PAK depletion extends longevity and delays age-related phenotypes in model organisms.
- PAK inhibitors show potential in modulating aging processes.
Conclusions:
- PAKs function as oncogenic and aging kinases.
- Targeting PAK1 may represent a novel therapeutic strategy for cancer and age-related conditions.
- PAK1 inhibitors could promote healthy longevity and potentially reduce cancer side effects.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway
cAMP-dependent Protein Kinase Pathways

